Articles in IPOs

Renaissance Capital

Shake Shack prices IPO at $21, above upwardly revised $17-$19 range

Shake Shack, a well known upscale fast casual burgher chain with 63 restaurants across 31 cities and nine countries, raised $105 million by offering 5 million shares at $21, above the upwardly... Read >>

Renaissance Capital

Sun money: Sol-Wind Renewable Power LP sets terms for $174 million IPO

Sol Wind Renewable Power LP, which owns a portfolio of contracted solar generation assets, announced terms for its IPO on Thursday. The New York, NY based company plans to raise $174 million by... Read >>

Renaissance Capital

Healthcare tech IPO Inovalon sets terms to raise $500 million in February

Inovalon Holdings, which provides healthcare analytics to payors, providers and pharmas, announced terms for its IPO on Thursday. The Bowie, MD based company plans to raise $500 million by... Read >>

Renaissance Capital

Presbia prices IPO at $10, below the range

Presbia, which sells surgically implanted lenses to correct age related vision loss, raised $42 million by offering 4.2 million shares at $10, below the $11 to $13 range. Presbia will list on the... Read >>

Renaissance Capital

Entellus Medical prices upsized IPO at $17, the high end of the range

Entellus Medical, which sells a minimally invasive treatment to open obstructed sinus pathways, raised $78 million by offering 4.6 million shares (up from 4.4 million) at $17, the high end of the... Read >>

Renaissance Capital

Flexing its muscles: Flex Pharma prices upsized IPO above the range at $16

Flex Pharma, which is developing dietary supplements for the treatment of muscle cramps and spasms, raised $86 million by offering 5.4 million shares at $16, above the range of $12 to $14. The... Read >>

Renaissance Capital

Cancer biotech Kolltan Pharmaceuticals withdraws $86 million IPO

Kolltan Pharmaceuticals, an early stage biotech developing antibodies to treat solid tumors, withdrew its plans for an initial public offering on Wednesday. The company originally filed for an $86... Read >>

Renaissance Capital

It's electric: Spark Therapeutics increases proposed IPO deal size by 48% to $130 million

Spark Therapeutics, which is developing gene therapy treatments for orphan retinal dystrophies, raised the proposed deal size for its upcoming IPO on Wednesday. The Philadelphia, PA based company... Read >>

Renaissance Capital

Ascendis Pharma prices upsized IPO at $18, the high end of the range

Ascendis Pharma, which is developing long acting treatments for growth hormone deficiency, raised $108 million by offering 6 million shares (vs. 5 million originally planned) at $18, the high end... Read >>

Renaissance Capital

Shake Shack increased proposed range to $17 to $19

Shake Shack, a fast casual burger chain with 36 US and 27 international locations, raised the proposed deal size for its upcoming IPO on Wednesday. The New York, NY based company now plans to... Read >>